Âé¶¹´«Ã½Ó³»­

Âé¶¹´«Ã½Ó³»­

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Mutations in the Glucocerebrosidase Gene and Parkinson's Disease
Movement Disorders
(-)
040
Authors/Disclosures
Lorraine N. Clark, PhD (Columbia University) No disclosure on file
Noorie Pednekar, MD No disclosure on file
Sharon Chiang, MD, PhD (UCSF) Dr. Chiang has stock in EpilepsyAI. Dr. Chiang has received research support from UCSF Clinical and Translational Science Institute UL1 TR001872. The institution of Dr. Chiang has received research support from NIH R25 NS070680 .
No disclosure on file
No disclosure on file
No disclosure on file
Stanley Fahn, MD, FÂé¶¹´«Ã½Ó³»­ Dr. Fahn has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Stoparkinson Healthcare Systems, LLC; . Dr. Fahn has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Retrophin Inc . Dr. Fahn has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Publishers . Dr. Fahn has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Kirkland & Ellis. Dr. Fahn has received publishing royalties from a publication relating to health care.
Daniel Goldenholz, MD, PhD (Beth Israel Deaconess Medical Center) Dr. Goldenholz has received personal compensation in the range of $0-$499 for serving as a Consultant for Neuro Event Labs. Dr. Goldenholz has received personal compensation in the range of $0-$499 for serving as a Consultant for IDR. Dr. Goldenholz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Livanova . Dr. Goldenholz has received personal compensation in the range of $0-$499 for serving as a Consultant for Health Advances . Dr. Goldenholz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Âé¶¹´«Ã½Ó³»­. Dr. Goldenholz has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for ACNS. Dr. Goldenholz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AES. Dr. Goldenholz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Nebraska Neurological Society . The institution of Dr. Goldenholz has received research support from NIH. The institution of Dr. Goldenholz has received research support from BIDMC. Dr. Goldenholz has a non-compensated relationship as a advisor with Eysz that is relevant to Âé¶¹´«Ã½Ó³»­ interests or activities. Dr. Goldenholz has a non-compensated relationship as a advisor with Epilepsy AI that is relevant to Âé¶¹´«Ã½Ó³»­ interests or activities.
Ruth Ottman, PhD (Columbia University) No disclosure on file
Claude Gaultier Claude Gaultier has received personal compensation in the range of $0-$499 for serving as a Consultant for biogen. Claude Gaultier has received personal compensation in the range of $0-$499 for serving as a Consultant for sanofi.
No disclosure on file
Karen S. Marder, MD, MPH, FÂé¶¹´«Ã½Ó³»­ (Columbia University) Dr. Marder has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Marder has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Marder has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Parkinson's Foundation . Dr. Marder has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CHDI. Dr. Marder has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PTC therapeutics. Dr. Marder has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer LTD. The institution of Dr. Marder has received research support from Vaccinex. The institution of Dr. Marder has received research support from Genentech. The institution of Dr. Marder has received research support from Triplet Therapeutics. The institution of Dr. Marder has received research support from Prilenia.
John M. Stern, MD, FÂé¶¹´«Ã½Ó³»­ Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB Pharma. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for SK Life Science. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurelis. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Ceribell. Dr. Stern has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Jazz Pharma. Dr. Stern has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for LivaNova. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurelis. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for LivaNova. Dr. Stern has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sunovion. Dr. Stern has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Jazz. Dr. Stern has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for SK Life Sciences. Dr. Stern has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MedLink Neurology. Dr. Stern has stock in DEARhealth. Dr. Stern has stock in Ceribell. Dr. Stern has received publishing royalties from a publication relating to health care. Dr. Stern has received publishing royalties from a publication relating to health care. Dr. Stern has received publishing royalties from a publication relating to health care. Dr. Stern has received publishing royalties from a publication relating to health care.
No disclosure on file